ArticleJournal of neurosurgery. Case lessons2026
Two-level fusion for Bertolotti syndrome and concomitant adjacent segment disease: patient series.
Article in Journal of neurosurgery. Case lessons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundBertolotti syndrome is characterized by low back pain and a lumbosacral transitional vertebra (LSTV). LSTVs are classified into four types by the Castellvi system. Pain is thought to be due to degeneration or strain at a pseudoarticulation of the enlarged transverse process and the sacrum. At times, patients with Bertolotti syndrome develop severe degeneration and/or instability adjacent to the LSTV. Treatments range from conservative measures, such as therapeutic injections, to surgical interventions, such as fusion, resection, and decompression. OBSERVATIONS: This study examines two-level fusion surgeries performed via open, minimally invasive (MIS), or robotic approaches for Bertolotti syndrome and associated adjacent level degeneration. Eight patients were identified retrospectively. All underwent two-level fusion at L4-L5-S1 or L5-L6-S1. Six surgeries were MIS (one with robotic assistance), and two were open. MIS/robotic procedures had a median surgery duration of 3 hours 30.5 minutes and a median blood loss of 50 ml, while open surgeries averaged 5 hours 49.5 minutes, with 300 ml of blood loss. No patients had 90-day or 12-month readmissions or reoperations. LESSONS: Patients undergoing two-level fusion for Bertolotti syndrome had similar outcomes across surgical approaches. Both groups improved in physical health above the minimal clinically important difference. https://thejns.org/doi/10.3171/CASE25551.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.